Radiotherapy Patient Education With Virtual Reality
RADIOACTIVE
RADIOACTIVE - Radiotherapy Patient Education With Virtual Reality
1 other identifier
interventional
150
1 country
1
Brief Summary
The purpose of this research study is to investigate the impact of virtual reality experiences on individuals undergoing radiotherapy, aiming to assess whether this immersive technology can reduce anxiety and enhance patient overall treatment satisfaction. By comparing different virtual reality techniques and a standard informational video, the study seeks to identify optimal strategies for leveraging virtual reality to improve the patient experience during radiotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable anxiety
Started Dec 2024
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedStudy Start
First participant enrolled
December 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 19, 2025
December 1, 2025
2.1 years
July 11, 2024
December 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Level of Anxiety measured by scores on the State-Trait Anxiety Inventory (STAI)
The State-Trait Anxiety Inventory (STAI) is a brief and widely used self-assessment tool validated to measure anxiety in individuals undergoing medical therapy or other stressful experiences. The scale consists of 20 items, with separate scales for trait and state. Scores on the Likert scale, ranging from 0 to 4, provide an assessment of symptom severity in patients dealing with various medical conditions (state) as well as baseline status (trait). Higher scores indicate higher levels of anxiety.
Baseline, up to 2 weeks
Secondary Outcomes (3)
Change in Level of Anxiety measured by scores on the State-Trait Anxiety Inventory (STAI)
Baseline, up to 8 weeks
Change in Radiation Oncology Knowledge Assessment Survey (ROKAS)
baseline, up to 1 day (after intervention)
Change in Health-Related Quality of Life measured by the Functional Assessment of Cancer Therapy-General (FACT-G) Questionnaire
Baseline, up to 8 weeks
Study Arms (3)
Informational Video
ACTIVE COMPARATORParticipants in this group will watch a two-dimensional (2D) informational video that explains the radiation treatment process. Total participation is up to 8 weeks.
Virtual Reality: 1st Person Perspective
EXPERIMENTALParticipants in this group will have a virtual reality experience presented from a first-person perspective. Participants will wear a Meta Quest Pro virtual reality headset, immersing themselves in a scenario that replicates the radiation treatment process. Total participation is up to 8 weeks.
Virtual Reality: 3rd Person Perspective
EXPERIMENTALParticipants in this group will wear a Meta Quest Pro virtual reality headset and use virtual reality to observe the radiation treatment scenario from a standing position within the room, enabling them to witness both the CT scan and radiation machine from an external viewpoint. Total participation is up to 8 weeks.
Interventions
A 30-minute informational video. The two dimensional (2D) video provides information about the radiotherapy process. Participants will receive this one-time intervention in-person, prior to treatment.
A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a third-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.
A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a first-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.
Eligibility Criteria
You may qualify if:
- Histologically proven cancer
- ≥18 years of age
- Able to speak and read English and/or Spanish
- Receiving radiotherapy at the University of Miami
You may not qualify if:
- Prior radiation therapy
- Pregnant or nursing women
- Men or women of childbearing potential who are unwilling to employ adequate contraception
- Patients unable to consent or are prisoners
- Participants with impaired decision-making capacity
- Any serious illness or medical condition that would compromise patient safety during virtual reality as judged by the treating physician
- Unwilling or unable to watch virtual reality video
- Unwilling to fill out survey forms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin J Rich, MD
University of Miami
- PRINCIPAL INVESTIGATOR
Crystal Chen, PhD
University of Miami
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Clinical
Study Record Dates
First Submitted
July 11, 2024
First Posted
July 17, 2024
Study Start
December 4, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 19, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share